000307566 001__ 307566
000307566 005__ 20260109120356.0
000307566 0247_ $$2doi$$a10.1038/s41375-025-02853-7
000307566 0247_ $$2pmid$$apmid:41501502
000307566 0247_ $$2ISSN$$a0887-6924
000307566 0247_ $$2ISSN$$a1476-5551
000307566 037__ $$aDKFZ-2026-00062
000307566 041__ $$aEnglish
000307566 082__ $$a610
000307566 1001_ $$aPatterson, S. D.$$b0
000307566 245__ $$aSequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or bone marrow.
000307566 260__ $$aLondon$$bSpringer Nature$$c2026
000307566 3367_ $$2DRIVER$$aarticle
000307566 3367_ $$2DataCite$$aOutput Types/Journal article
000307566 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1767884604_3506150$$xLetter
000307566 3367_ $$2BibTeX$$aARTICLE
000307566 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000307566 3367_ $$00$$2EndNote$$aJournal Article
000307566 500__ $$a#NCTZFB9# / epub
000307566 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000307566 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000307566 7001_ $$aGottschalk, A.$$b1
000307566 7001_ $$aHayden, C.$$b2
000307566 7001_ $$aYoung, R.$$b3
000307566 7001_ $$aHair, A.$$b4
000307566 7001_ $$00000-0003-4663-4191$$aJørgensen, H. G.$$b5
000307566 7001_ $$00000-0001-9902-3170$$aWheadon, H. W.$$b6
000307566 7001_ $$00000-0002-1710-1794$$aApperley, J. F.$$b7
000307566 7001_ $$00000-0002-2524-1199$$aGlauche, I.$$b8
000307566 7001_ $$aClark, R. E.$$b9
000307566 7001_ $$00000-0002-7655-016X$$aCopland, M.$$b10
000307566 7001_ $$00000-0002-6741-0608$$aRoeder, I.$$b11
000307566 773__ $$0PERI:(DE-600)2008023-2$$a10.1038/s41375-025-02853-7$$pnn$$tLeukemia$$vnn$$x0887-6924$$y2026
000307566 909CO $$ooai:inrepo02.dkfz.de:307566$$pVDB
000307566 9101_ $$0I:(DE-588b)2036810-0$$60000-0002-6741-0608$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000307566 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000307566 9141_ $$y2026
000307566 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-01-07$$wger
000307566 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-07
000307566 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-07
000307566 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-07
000307566 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-07
000307566 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-07
000307566 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2025-01-07
000307566 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-07
000307566 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-07
000307566 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-07
000307566 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLEUKEMIA : 2022$$d2025-01-07
000307566 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-07
000307566 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-07
000307566 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bLEUKEMIA : 2022$$d2025-01-07
000307566 9201_ $$0I:(DE-He78)DD04-20160331$$kDD04$$lKoordinierungsstelle NCT Dresden$$x0
000307566 980__ $$ajournal
000307566 980__ $$aVDB
000307566 980__ $$aI:(DE-He78)DD04-20160331
000307566 980__ $$aUNRESTRICTED